Marybeth Nelson
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunodeficiency and Autoimmune Disorders
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 12
- Chronic Lymphocytic Leukemia Research 12
-
- Lymphoma Diagnosis and Treatment 7
- Co-authors
- Frank G. Haluska (1 shared paper)Israel Lowy (1 shared paper)Michael T. Jaklitsch (1 shared paper)Michael V. Seiden (1 shared paper)F. Stephen Hodi (1 shared paper)Darryl A. Oble (1 shared paper)Nikhil H. Ramaiya (1 shared paper)Alan J. Korman (1 shared paper)
- Journals
- Blood (9 papers)Journal of Clinical Oncology (3 papers)Proceedings of the National Academy of Sciences (1 paper)Leukemia & lymphoma (1 paper)Clinical Lymphoma & Myeloma (2 papers)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Marybeth Nelson
17 papers receiving 781 citations
Hit Papers
Peers
Comparison fields: 5 of 48
- Immunology 487
- Genetics 243
- Oncology 438
- Pathology and Forensic Medicine 209
- Hematology 108
Countries citing papers authored by Marybeth Nelson
This map shows the geographic impact of Marybeth Nelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marybeth Nelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marybeth Nelson more than expected).
Fields of papers citing papers by Marybeth Nelson
This network shows the impact of papers produced by Marybeth Nelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marybeth Nelson. The network helps show where Marybeth Nelson may publish in the future.
Co-authors
The 25 scholars most cited alongside Marybeth Nelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients Hit paper breakdown → | 2008 | 488 |
| 2 | 2009 | 187 | |
| 3 | 2008 | 37 | |
| 4 | Enhanced interferon-gamma (IFN) production by lymph node cells from autoimmune (MRL/1, MRL/n) mice. | 1989 | 28 |
| 5 | 2008 | 11 | |
| 6 | 2008 | 9 | |
| 7 | 2008 | 6 | |
| 8 | 2007 | 5 | |
| 9 | 2008 | 4 | |
| 10 | 2007 | 3 | |
| 11 | 2007 | 3 | |
| 12 | 2009 | 3 | |
| 13 | 2008 | 2 | |
| 14 | 2007 | 1 | |
| 15 | 2009 | 1 | |
| 16 | 2007 | 1 | |
| 17 | 2009 | 1 |
About Marybeth Nelson
Marybeth Nelson is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Molecular Biology and Immunology, having authored 17 papers that have together received 790 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (7 papers), Chronic Myeloid Leukemia Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Protein Degradation and Inhibitors (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Eosinophilic Disorders and Syndromes (2 papers). The work is most often cited by research in Immunology (487 citations), Genetics (243 citations), Oncology (438 citations), Pathology and Forensic Medicine (209 citations) and Hematology (108 citations). Marybeth Nelson has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Frank G. Haluska, Israel Lowy, Michael T. Jaklitsch, Michael V. Seiden, F. Stephen Hodi, Darryl A. Oble, Nikhil H. Ramaiya, Alan J. Korman, Glenn Dranoff and Andrea Kruse. Their work appears in journals such as Blood, Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, Leukemia & lymphoma and Clinical Lymphoma & Myeloma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.